Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label supplementary and extension study of etanercept in ankylosing spondylitis
2006-001061-42Phase 4Completed
- Sponsor
- Wyeth
- Start
- Jun 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in ankylosing spondylitis (AS), sponsored by Wyeth. Primary endpoints: Quality of life assessment, Health care resource utilization and 1 more. Started Jun 2006; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2006-001061-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001061-42.